Termination of proposed sale and leaseback transaction
Open PDF
| Stock | Little Green Pharma Ltd (LGP.ASX) |
|---|---|
| Release Time | 19 Mar 2026, 9:28 a.m. |
| Price Sensitive | Yes |
This feature provides summaries of price-sensitive announcements for companies followed by users on InvestorPA.
The summaries are generated by large language models so please interpret with care.
Termination of proposed sale and leaseback transaction
Key Points
- Little Green Pharma Ltd (ASX:LGP) announced termination of proposed sale and leaseback of production facility
- Parties were unable to reach commercial agreement on certain conditions precedent
- Termination will not impact LGP's business or operations
Full Summary
Little Green Pharma Ltd (ASX:LGP) refers to its previous announcement dated 19 February 2026 where it had signed a Contract to sell and lease back its production facility in South-West Western Australia, subject to various conditions precedent. The Company has now confirmed that the Parties were unable to reach commercial agreement in relation to certain matters the subject of conditions precedent in the Contract, meaning the Contract has now terminated in accordance with its terms. This means the proposed sale and leaseback will not proceed and LGP will continue to own the production facility. Termination of the proposed sale and leaseback is not expected to impact LGP's business or operations.
Sign in to get more information about the company, including guidance changes and other insights.
Sign In